Introduction {#S1}
============

Development of a functional central nervous system (CNS) relies on mechanisms that assign precise positional identity onto dividing neural progenitors. Signaling factors released from localized sources within the embryo subdivide the nascent neural tube along two principal axes: dorso-ventral and rostro-caudal. Rostro-caudal patterning is established in early neural progenitors around the time of neural tube closure^[@R1]^ and in the developing hindbrain and spinal cord it is manifested by the differential expression of a phylogenetically conserved family of Hox transcription factors^[@R1]-[@R5]^. Although the activity of rostro-caudal patterning signals is transient, it has a lasting effect on the pattern of *Hox* gene expression that is maintained for the rest of embryonic development^[@R1]^. Maintenance of *Hox* gene expression is critical for the generation of segment-specific types of spinal nerve cells including columnar and pool specific motor neuron subtypes necessary for the proper wiring and functionality of spinal motor circuits^[@R2]-[@R4]^.

Mechanisms that control the establishment and maintenance of *Hox* gene expression have been under intense scrutiny. Mouse *Hox* genes are organized in four chromosomal clusters each harboring a subset of 13 paralogous *Hox* genes. Individual genes within these clusters are expressed in patterns that are spatially and temporally collinear with their physical chromosomal organization^[@R6][@R7]^. Mutations in the Polycomb group (PcG) complex of histone modifying enzymes lead to defects in the maintenance of *Hox* gene expression^[@R8],\ [@R9]^, indicating that epigenetic mechanisms and chromatin remodeling play an important role in the process of rostro-caudal patterning. *Hox* chromatin is found in a compacted and repressed state in pluripotent embryonic stem cells (ESCs)^[@R10]^ characterized by high density of histone H3 lysine 27 trimethyl modifications (K27me3) deposited by the PcG complex^[@R11],\ [@R12]^. The distribution of K27me3 modifications is altered during embryonic development resulting in a clearance of repressive modifications from chromatin domains harboring transcribed *Hox* genes^[@R13]-[@R15]^. Based on a correlation between chromatin modifications and *Hox* gene expression, it has been proposed that progressive removal of the repressive modifications from *Hox* chromatin controls the temporally progressive collinear pattern of *Hox* gene expression^[@R14]^.

Rostro-caudal patterning of the embryo is controlled by diffusible patterning signals. Specification of cervical, brachial and thoracic spinal cord identity depends on opposing gradients of retinoic acid (RA) and fibroblast growth factor (FGF) signals^[@R5],\ [@R16]-[@R18]^. RA secreted by paraxial mesoderm activates retinoid receptors (RARs) bound to genomic sites and initiates the recruitment of additional RARs within Hox chromatin domains harboring *Hox1-Hox5* paralog genes^[@R19]^. FGF signaling activates expression of more caudal *Hox6-9* paralog genes controlling the brachial and thoracic spinal identity^[@R5],\ [@R16]-[@R18]^. Caudal type homeobox protein Cdx2 is a candidate transcription factor linking FGF signaling to the regulation of caudal brachial and thoracic identity^[@R18]^. Wnt and FGF signals jointly induce the expression of Cdx2^[@R20]-[@R22]^ and Cdx2 binding sites have been identified in a *cis*-regulatory element located between *Hoxc8* and *Hoxc9* genes^[@R23]^.

To study dynamic interactions between extrinsic signals and changes in chromatin architecture during rostro-caudal patterning, we developed an in vitro differentiation system that faithfully recapitulates normal development of cervical and brachio-thoracic spinal motor neurons. We provide evidence that patterning signals specifying cervical and brachio-thoracic identity activate RARs and Cdx2 transcription factors that are recruited to distinct *Hox* chromatin domains. We demonstrate that this pattern of repressive H3K27me3 modifications is rapidly altered following the exposure to rostro-caudal patterning signals. The repressive modifications are cleared from *Hox* chromatin domains occupied by RARs or Cdx2 transcription factors in a domain-wide saltatory process, instead of the proposed temporally progressive pattern of a shifting boundary between repressed and accessible chromatin. We propose that changes in H3K27me3 chromatin modifications are controlled by transient patterning signals and that stable maintenance of repressed and accessible *Hox* chromatin domains from progenitors to postmitotic motor neurons encodes the positional identity of differentiating cells and ensures proper specification of motor neuron subtype identity. Based on our findings we propose a comprehensive model of rostro-caudal patterning that integrates effects of extrinsic patterning signals, activation of developmentally regulated transcription factors, and changes in *Hox* chromatin modifications during neural development.

Results {#S2}
=======

Domain-wide changes in *Hox* chromatin modifications {#S3}
----------------------------------------------------

To characterize mechanisms that underlie establishment and maintenance of the rostro-caudal pattern of *Hox* gene expression, we examined molecular mechanisms leading to specification of spinal motor neurons with distinct rostro-caudal positional identities. We took advantage of an *in vitro* mouse embryonic stem cell (ESC) to spinal motor neuron differentiation system that recapitulates normal motor neuron development in a highly homogeneous and purely neural context^[@R24]^. This system eliminates potentially confounding influences of mesodermal and endodermal lineages in the developing embryo. The high yield and efficiency of motor neuron differentiation makes this system amenable to analysis of temporal changes in chromatin modifications by chromatin immunoprecipitation (ChIP) analysis^[@R25]^. ESCs were converted to cervical spinal motor neurons by joint exposure of cells on Day 2 of differentiation to retinoic acid (RA) and ventralizing signal sonic hedgehog agonist (Hh)^[@R24]^. RA treatment triggers the recruitment of retinoic acid receptor (RAR) to genomic sites localized within the 3′ end of *Hox* clusters ^[@R19]^, leading to the specification of rostral cervical motor neurons expressing Hox4 and Hox5 paralog transcription factors by Day 6 of differentiation^[@R16],\ [@R24]^ ([Fig. 1A](#F1){ref-type="fig"}).

To understand how RA signaling is translated into a developmentally stable pattern of *Hox* gene expression, we examined changes in the distribution of repressive PcG mediated histone H3 modifications (H3K27me3 referred to as "K27me3") that were previously implicated in the maintenance of *Hox* gene expression patterns. ChIP analysis revealed that the density and distribution of K27me3 modifications changed dramatically during the differentiation of ESCs into motor neurons. While the *Hox* clusters are covered by a high density of K27me3 modifications at ESC stage, the repressive mark was reduced to a background level in a 3′ *Hox* chromatin domain spanning *Hox 1-5* genes in Day 7 motor neurons ([Fig. 1B](#F1){ref-type="fig"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). The K27me3-depleted domain corresponds to the domain bound by RARs after the addition of RA and harbors all *Hox* genes expressed in cervical motor neurons ([Fig. 1B](#F1){ref-type="fig"})^[@R19]^. Together, these data indicate that large-scale changes in histone modification patterns accompany differentiation of ESCs into spinal motor neurons of defined rostro-caudal positional identity, recapitulating embryonic development.

Chromatin state analysis of tail buds at different developmental stages suggested a directional and temporally progressive removal of K27me3 modifications from *Hox* clusters ^[@R14]^. To determine the dynamics of K27me3 removal during neuronal development, we performed a time-series analysis of histone modifications during ESC differentiation into spinal motor neurons. The density of K27me3 modifications over *Hox* chromatin remained high until the addition of patterning signals on Day 2 of differentiation ([Fig. 1C](#F1){ref-type="fig"} and [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). After one day of RA/Hh treatment (Day 3 of differentiation), we observed a domain wide decrease in the density of K27me3 modifications spanning the *Hox1-5* genes ([Fig. 1C](#F1){ref-type="fig"} and [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). By Day 4 (motor neuron progenitor stage) the pattern of K27me3 modifications over *Hox* genes was indistinguishable from the one observed in postmitotic motor neurons on Day 7 of differentiation ([Fig. 1C](#F1){ref-type="fig"} and [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). The rapid removal of repressive modifications is driven by RA treatment. Day 2 embryoid bodies that were treated with RA for 8 hours exhibited significant loss of repressive modifications in *Hox1-5* domain compared to control untreated cells ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Analysis of Ring1b and Suz12, components of Polycomb repressive complexes PRC1 (involved in chromatin compaction and repression of transcription ^[@R26]^ and PRC2 (methyltansferase complex required for the maintenance of H3K27me3), revealed that both complexes are rapidly displaced from activated Hox chromatin domain following RA treatment ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Jointly, these results indicate that RA-mediated activation and recruitment of RARs to locations within *Hox1-5* chromatin initiates saltatory (rapid, domain-wide) removal of Polycomb repressors and K27me3 histone modifications during motor neuron differentiation.

To directly compare the kinetics of K27me3 removal with transcription of *Hox* genes employing the same platform, we profiled histone H3 lysine 79 dimethyl modifications ("K79me2"). K79me2 modifications are correlated with the presence of elongating Pol2 complex and thus can be used as a proxy for transcriptional activity^[@R27]^. In contrast to the domain-wide changes in K27me3 density, a time-series analysis revealed temporally and spatially progressive accumulation of K79me2 modifications within the K27me3 depleted domain during spinal motor neuron differentiation ([Fig. 1C](#F1){ref-type="fig"}). This is consistent with observed temporally progressive and collinear activation of Hox gene expression during motor neuron differentiation ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}) and reminiscent of the progressive collinear activation of *Hox* gene transcription following RA treatment of embryonal carcinoma cell lines ^[@R6]^. The dichotomy between the dynamics of K27me3 and K79me2 modifications is best illustrated by a comparison of *Hoxa1* and *Hoxa5* genes. While the rapid clearance of K27me3 from *Hoxa1* coincides with K79me2 accumulation, the similarly rapid clearance of K27me3 modifications from the *Hoxa5* gene is followed by a delayed, gradual accumulation of K79me2 modifications ([Fig. 1D](#F1){ref-type="fig"}). Based on these observations, we conclude that *Hox* chromatin is partitioned into transcriptionally accessible (K27me3 low) and repressed (K27me3 high) domains in response to retinoid signaling. The rapid kinetics of K27me3 clearance cannot explain the temporally progressive pattern of *Hox* gene transcription indicating that the level of PcG repressive chromatin modifications is permissive rather than instructive for activation of *Hox* gene expression.

Suz12 activity is required to maintain *Hox* gene expression {#S4}
------------------------------------------------------------

To study the role of K27me3 modifications we asked whether ESCs harboring mutations in key PRC2 components (Eed, Ezh2, and Suz12) can be directed to differentiate into motor neurons in vitro. Genetic inactivation of PRC2 complex leads to the loss of K27me3 modifications and early embryonic lethality^[@R28]^. Likewise, ESC lines in which PRC2 function is disrupted (Eed^−/−^, Ezh2^−/−^)^[@R29],\ [@R30]^ failed to differentiate along neural lineage. However, we determined that previously reported β-gal gene-trap mutation of Suz12 ^[@R31]^ is a hypomorph and ESCs homozygous for this allele maintain a low level of K27me3 ([Fig. 2A](#F2){ref-type="fig"} and [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). The hypomorphic line was able to differentiate into motor neurons, albeit with a lower efficiency ([Fig. 2B](#F2){ref-type="fig"}). Analysis of *Hox* gene expression in Suz12^βgal/βgal^ ESCs differentiated into cervical spinal motor neurons revealed a significant increase in the expression of brachial spinal cord *Hox* genes *Hoxc6* and *Hoxa7* ([Fig. 2B and 2C](#F2){ref-type="fig"}) as compared to wild type cells. Consistent with this, a subset of the differentiated Suz12^β-gal/β-gal^ cells acquired the identity of limb innervating motor neurons (Foxp1^+^, Raldh2^+^, Lhx3^−^) found in brachial but not cervical spinal cord ([Fig. 2B and 2D](#F2){ref-type="fig"}). Importantly, Suz12^β-gal/β-gal^ mutant cells retained collinear expression of *Hox* genes during motor neuron differentiation ([Fig. 2E](#F2){ref-type="fig"}). Together these findings provide compelling evidence that the PRC2 complex is critical for maintained repression of *Hox* genes located in K27me3-high chromatin territory and for proper specification of motor neuron subtype identity.

Wnt3A and FGF2 signals caudalize motor neurons {#S5}
----------------------------------------------

Our observation that RA signaling leads to the clearance of repressive chromatin modifications only from a defined set of rostral *Hox* genes suggested that other patterning signals might control the removal of K27me3 modifications from more caudal *Hox* chromatin domains. To test this hypothesis, we examined mechanisms underlying the specification of more caudal spinal motor neurons. Wnt and FGF patterning signals are necessary for the specification of brachial and thoracic motor neurons expressing Hox6-9 transcription factors ^[@R16]^ and are sufficient to induce caudal spinal *Hox* gene expression in chick neural tube explants ^[@R17]^. We have systematically optimized caudalization of differentiating ESCs by Wnt3a and FGF2 treatment and identified conditions (150 ng/ml Wnt3a; 100 ng/ml FGF2) that gave rise to a mixture of motor neurons expressing the thoracic marker Hoxc9 (28.9 ± 3.1% of all motor neurons) and brachial markers Hoxc6 (20.8 ± 2.4% of all motor neurons) and Hoxc8 (50.4 ± 7.1 % of all motor neurons), as well as the limb innervating motor neuron marker FoxP1 (28.6 ± 3.9 % of all motor neurons) ^[@R32],\ [@R33]^ ([Fig. 3A-C](#F3){ref-type="fig"}).

To identify transcription factors that mediate induction of *Hox6-9* genes by extrinsic Wnt and FGF signals, we focused on the evolutionarily conserved family of caudal homeobox (Cdx) transcription factors that are necessary for the development of caudal structures^[@R18],\ [@R34]^. Of the three mammalian Cdx homologues, Cdx2 exhibited the greatest degree of up-regulation (336 ± 22 fold) at 24 hours following Hh/RA/Wnt/FGF treatment ([Fig. 3D](#F3){ref-type="fig"}). Activation of Cdx2 expression was dependent on a synergistic action of Wnt and FGF, as treatment of cells with Wnt3a alone^[@R16]^ or FGF2 alone failed to induce high levels of Cdx2 expression ([Fig. 3D](#F3){ref-type="fig"} and [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Cdx2 protein expression was transient, dropping to basal levels by 48 hours of treatment ([Fig. 3E](#F3){ref-type="fig"}). These results raise the possibility that transiently expressed Cdx2 might mediate the synergistic caudalizing activity of Wnt and FGF signals and regulate *Hox* gene expression.

Cdx2 induces caudal *Hox* expression in motor neurons {#S6}
-----------------------------------------------------

To determine whether Cdx2 activity is sufficient to activate caudal *Hox* gene expression independently of Wnt and FGF signaling, we generated a doxycycline (Dox) inducible V5-tagged Cdx2 ESC line (iCdx2) ^[@R25]^. Functionality of the epitope tagged Cdx2 is demonstrated by its ability to suppress Oct4 expression following its induction in ESCs ^[@R35]^ ([Fig. 4A](#F4){ref-type="fig"}). Next, we asked if the expression of Cdx2 is sufficient to induce caudal *Hox* gene expression in the context of RA/Hh differentiated cervical motor neurons. Combined doxycycline and FGF2 treatment of RA/Hh treated embryoid bodies on Day 3 resulted in an efficient induction of Hoxc6, Hoxc8 and Hoxd9 expression ([Fig. 4B-D](#F4){ref-type="fig"}). Expression of Cdx2 had no effect on *Hox* gene expression in the presence of FGF receptor inhibitor PD173074 ([Supplementary Fig. 5B](#SD1){ref-type="supplementary-material"}) and similarly, FGF2 treatment alone was not sufficient to induce caudal *Hox* gene expression ([Fig. 4B and 4C](#F4){ref-type="fig"}). These results indicate that FGF signaling plays a dual role during neural rostro-caudal patterning - first it synergizes with Wnt to induce Cdx2 expression, and second it synergizes with Cdx2 to activate caudal *Hox* gene expression.

Cdx2 binds and controls *Hox* chromatin modifications {#S7}
-----------------------------------------------------

If Cdx2 directly regulates *Hox* gene expression, it should bind to genomic locations within *Hox* clusters. We performed Cdx2 ChIP-seq experiments 48 hours after doxycycline treatment and identified 39,493 Cdx2 binding sites (*p*\<0.001), including 118 binding sites within the *Hox* clusters ([Fig. 5A](#F5){ref-type="fig"}). The primary DNA sequence motif overrepresented under Cdx2 ChIP-seq peaks corresponds to the previously described Cdx2 binding motif GYMATAAA ^[@R36]^ ([Fig. 5B](#F5){ref-type="fig"}). Cdx2 selectively binds within the *Hox1* to *Hox9* paralog gene chromatin domain ([Fig. 5C](#F5){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}) and the 5′ extent of Cdx2 association with *Hox* chromatin is in register with the last 5′ *Hox* gene (*Hox9* paralogs) induced in caudalized motor neurons ([Fig 5C](#F5){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Taken together, these results revealed that Cdx2 associates with regulatory regions proximal to transcriptionally active *Hox* genes, suggesting its involvement in the direct regulation of *Hox* gene expression during the specification of brachial and thoracic motor neurons.

To determine whether transient expression of Cdx2 caused changes in PcG mediated chromatin modifications, we measured the status of K27me3 by ChIP-seq analysis 36 hours after the Dox and FGF treatment (equivalent to 24 hours of Cdx2 expression). We observed a domain-wide removal of the repressive histone modifications up to a boundary between *Hox9* and *Hox10* paralogs ([Fig. 5C](#F5){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). The K27me3 depleted domain spans the genomic territory occupied by Cdx2 transcription factor and harbors *Hox* genes expressed by Cdx2/FGF2 caudalized motor neurons ([Fig. 5C](#F5){ref-type="fig"} and [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). These results suggest that, analogous to RA signaling, transient expression of Cdx2 in neural progenitors results in a global change in the *Hox* chromatin landscape, making a subset of brachial and thoracic *Hox* genes available for transcription in postmitotic spinal motor neurons.

Discussion {#S8}
==========

We have determined a sequence of molecular events leading from the reception of transient patterning signals to the establishment of lasting rostro-caudal identity in neural tissue. Based on the combined analysis of extracellular signals, transcription factors, and chromatin states, we conclude that activity of RA and Wnt/FGF patterning signals is transmitted by RAR and Cdx2 transcription factors that bind to discrete *Hox* chromatin domains. Transcription factor binding is accompanied by a saltatory clearance of repressive K27me3 histone modifications, partitioning *Hox* clusters into activated and repressed domains. The K27me3 pattern is maintained through progenitor cell divisions until postmitotic motor neurons, defining a rostro-caudally appropriate subset of *Hox* genes available for expression and specification of motor neuron subtype identity. Consistent with the notion that patterning signals controlling postmitotic motor neuron Hox gene expression act early in development, we have recently demonstrated that Hox genes are not properly induced during transcriptional programming of motor neurons from ESCs that bypasses neural progenitor stages^[@R37]^.

Analyses of chromatin states in developing embryos and differentiating ESCs revealed that the temporally progressive activation of *Hox* gene expression is paralleled by a shift of the boundary between K27me3 low and high *Hox* chromatin domains and by a visible chromatin decondensation ^[@R14],\ [@R38]^. These results admit two interpretations: (1) the removal of K27me3 progresses one gene at a time from 3′ to 5′ ends of each *Hox* cluster during the period of rostro-caudal patterning, or (2) the different observed chromatin states are the product of discrete signaling events acting on distinct *Hox* chromatin domains. The results presented in this work favor the latter interpretation.

Time-course analysis of changes in *Hox* chromatin modifications revealed removal of repressive modifications that is rapid (within 24 hours following RA treatment) and that does not progress in a directional 3′ to 5′ manner at the timescale examined (see the 8 hour time point \[Day2+ RA\] in [supplementary Fig S2](#SD1){ref-type="supplementary-material"}). Importantly, kinetics of K27me3 removal does not correlate with progressive upregulation of *Hox1-5* gene expression over a four day period. We propose that what appears like progressive directional removal of repressive modifications from *Hox* chromatin *in vivo*, is an effect of sequentially acting patterning signals, each initiating clearance of K27me3 modifications from a different subdomain of *Hox* chromatin. Early in development retinoids activate rostral *Hox1-5* domain expressed in the hindbrain and cervical spinal cord. Later specified brachial and thoracic segments are exposed to Wnt and FGF signals emanating from the node region^[@R17]^, leading to Cdx2 induction and activation of more posterior *Hox6-9* domains. We speculate that other combinations of signals including FGFs and Gdf11^[@R5],\ [@R39]^ will be involved in activation of *Hox10*-*Hox13* chromatin domain.

The rapid removal of K27me3 modifications is likely accompanied with relaxation of Hox chromatin and large scale chromatin remodeling ^[@R40]^. We observe that PRC1 protein Ring1b ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}), necessary for the maintenance of condensed and repressed Hox chromatin^[@R26]^, is rapidly displaced from the activated domain. Thus our data are consistent with the reported formation of differential chromatin boundaries at different developmental times and rostrocaudal spinal cord positions^[@R3],\ [@R14],\ [@R41]^ and with observed large scale remodeling of *Hox* chromatin observed by FISH^[@R10],\ [@R26],\ [@R38]^.

Maintenance of K27me3 high domains is necessary for stable repression of *Hox* genes. While complete clearance of K27me3 modifications in Eed and Ezh2 null ESCs is incompatible with neural differentiation, erosion of K27me3 modifications in a Suz12 hypomorph cell line results in a de-repression of brachial *Hox* genes in cervical motor neurons. Ectopic expression of *Hoxc6* and *Hoxc7* leads to a change in a subtype identity of resulting motor neurons and to generation of ectopic limb innervating motor neurons expressing Foxp1. These findings are consistent with the observed de-repression of caudal *Hox* genes in Polycomb complex mutants^[@R8],\ [@R9],\ [@R11]^, including a recent study demonstrating that downregulation of PRC1 gene *Bmi1* in the developing spinal cord in vivo leads to a de-repression of *Hoxc9* gene in brachial spinal cord and a conversion of brachial motor neurons to thoracic ones^[@R41]^.

The final expression pattern of *Hox* genes in the nervous system is highly complex and cannot be explained only by binary division of *Hox* chromatin into permissive and repressed territories. Expression of individual *Hox* genes within the permissive chromatin domain is fine-tuned by secondary transcriptional interactions. For example, brachial Hox4-8 transcription factors located in the permissive chromatin domain engage in cross-repressive interactions leading to the diversification of motor neurons into distinct motor pool subtypes^[@R2]^. Similarly, Hoxc9 transcription factor is critical for direct repression of cervical and brachial *Hox* genes (*Hox1-7*) in permissive chromatin territory, ensuring generation of motor neurons with proper thoracic identity^[@R3]^. Interestingly, these secondary repressive events do not lead to reacquisition of K27me3 repressive Polycomb-catalyzed modifications^[@R3]^ ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}).

Expression of *Hox* genes in developing limb mesenchyme is controlled by distal regulatory elements that are brought into physical proximity of *Hox* genes by chromatin looping^[@R42]^. However, the transcription factors binding to the distal regulatory elements have not been identified and the mechanisms through which these elements are recruited to the proximity of selected *Hox* genes remain unknown. We speculate that RAR and Cdx2 transcription factors bound within *Hox* genes might coordinate the long distance chromatin looping and provide the necessary local anchor points demarcating the precise chromatin domains to be activated during rostro-caudal patterning. Our observation that RAR and Cdx2 transcription factors bind in the vicinity of previously identified distal regulatory elements^[@R42]^ ([Fig. 6B](#F6){ref-type="fig"} and data not shown), raises the possibility that the long distance chromatin looping is based on homotypic RAR-RAR and Cdx2-Cdx2 interactions, analogous to the previously described long distance interactions among chromatin sites occupied by estrogen receptors^[@R43]^.

Based on our findings and previous reports, we propose a four-step model of *Hox* gene regulation during rostro-caudal patterning of the developing neural tube ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). First, patterning signals activate relevant transcription factors that bind to *cis* regulatory elements within *Hox* clusters and to distal enhancers resulting in chromatin looping. Second, the transcription factors recruit transactivators that initiate rapid, domain-wide clearance of repressive H3K27me3 modifications from the bound chromatin domains leading to chromatin decondensation and transcriptional activation of *Hox* genes. Third, the established permissive/repressive chromatin domains are maintained until the postmitotic stage. Fourth, secondary transcriptional regulations of individual *Hox* genes within activated domains lead to fine-grain patterns of *Hox* gene expression observed in postmitotic motor neurons.

Together, this study provides insight into the precisely orchestrated interplay between signaling molecules, transcription factors, and chromatin modifications that jointly contribute to neural tube patterning. These findings open new approaches for directed differentiation of ESCs to the caudal spinal cord nerve cells by extrinsic signals or by forced expression of Cdx2 transcription factor. The study highlights the utility of ESCs as an optimal system to study mechanisms governing embryonic development, to test the inferred principles, and eventually to employ the developmental logic for the production of cell types that will advance our understanding of the nervous system in health and disease.

Methods {#S9}
=======

Cell culture and motor neuron differentiation {#S10}
---------------------------------------------

Hb9-GFP (HBG3) Suz12^β-gal/β-gal^ and Eed mutant ES cells were differentiated as previously described ^[@R11],\ [@R24],\ [@R31]^. Briefly, ES cells were trypsinized and seeded at 5×10^5^ cells/ml in ANDFK medium (Advanced DMEM/F12:Neurobasal (1:1) Medium, 10% Knockout-SR, Pen/Strep, 2 mM L-Glutamine, and 0.1 mM 2-mercaptoethanol) to initiate formation of embryoid bodies (Day 0). Medium was exchanged on Day 1, Day 2 and Day 5 of differentiation. Patterning of embryoid bodies was induced by supplementing media on Day 2 with 1 μM all-*trans*-Retinoic acid (RA, Sigma) and 0.5 μM agonist of hedgehog signaling (SAG, Calbiochem). For Wnt and FGF differentiation of ES cells, 150 ng/ml Wnt3A (R&D Systems) and 100 ng/ml bFGF (PeproTech), were added along with RA and Hh on day 2. To generate caudal brachial and thoracic ES motor neurons using inducible *Cdx2* and FGF, *imCdx2-V5* ES cells were induced to differentiate on day 2 with RA and Hh. On day 3, cultures were treated with Doxycycline (Dox) (2 μg/ml) for 6 to 8 hours. Cultures were collected, washed with PBS, and treated with 100 nM RA, 100 ng/ml FGF, and 100 nM Hh agonist and medium was changed on day 5. For ChIP experiments, the same conditions were used but scaled to seed 1×10^7^ cells on Day 0. All differentiation was performed multiple times, analyzing at least three healthy cultures (n=1). Data distribution was assumed to be normal but this was not formally tested. No statistical methods were used to pre-determine sample sizes but our sample sizes are similar to those generally employed in the field.

Immunocytochemistry {#S11}
-------------------

Embryoid bodies were fixed with 4% paraformaldehyde in PBS, embedded in OCT (Tissue-Tek) and sectioned for staining: 24 hours at 4C for primary antibodies and 4 hours at RT for secondary antibodies. After staining, samples were mounted with Aqua Poly Mount (Polyscience). Images were acquired with a LSM 510 Carl Zeiss confocal microscope. Antibodies used in this study include: goat anti-Oct3/4 (ab27985, Abcam. 1:500), mouse monoclonal anti-Cdx2 (CDX2-88, BioGenex, 1:500), rabbit anti-Sox1 (kindly provided by Sara I. Wilson. 1:1,000), mouse anti-Isl1 and mouse anti-Hb9 (Developmental Studies Hybridoma Bank, 1:100), goat anti-Hoxc6 (Santa Cruz); rabbit anti-Hoxc4 (1:1,000), guinea pig anti-Hoxa5 (1:1,000), mouse anti-Hoxc8 mouse (1:100), guinea pig anti-Hb9 (1:5,000), rabbit and guinea pig anti-Foxp1 (1:1,000) are gifts from Tom Jessell. Alexa 488--(A11001, A11008,, FITC-(715-095-150, 706-095-148), Cy3-(715-165-150, 711-165-152, 706-165-148) and Cy5-(715-175-150, 711-175-152) conjugated secondary antibodies were used 1:2,000.

### Quantifications of ES motor neuron cultures {#S12}

To determine motor neuron differentiation efficiency and the fraction of Hoxc8 expressing ES motor neurons, EBs were dissociated on day 6 of differentiation. On day 7, we examined the number of Hb9^+^ cells and the total number of DAPI^+^ cells using immunocytochemistry or the expression of Hoxc8 in post-mitotic Hb9^+^ ES motor neurons.

Expression analysis {#S13}
-------------------

Total RNA was extracted from ES cells or embryoid bodies using Qiagen RNAeasy kit. For quantitative PCR (qPCR) analysis, cDNA was synthesized using SuperScript III (Invitrogen) and amplified using SYBR green brilliant PCR amplification kit (Stratagene) and Mx3000 thermocycler (Stratagene). For GeneChip expression analysis, RNA was amplified using Ovation amplification and labeling kit (NuGen) and hybridized to Affymetrix Mouse Genome 430 2.0 microarrays. Expression experiments were performed in biological triplicate for each analyzed time-point. Arrays were scanned using the GeneChip Scanner 3000. Data analysis was carried out using the affylmGUI BioConductor package ^[@R44]^. GCRMA normalization ^[@R45]^ was performed across all arrays, followed by linear model fitting using Limma ^[@R46]^. Differentially expressed genes were defined by ranking all probesets by the moderated *t*-statistic-derived *p*-value (adjusted for multiple testing using Benjamini & Hochberg's method^[@R47]^) and setting thresholds of *p*\<0.001 and a fold-change of at least 2. All arrays were submitted to the NIH GEO database under accession numbers GSE19372 (RA/Hh-dependent motor neuron differentiation timeseries) and GSE39422 (response to Cdx2 expression in motor neuron progenitors).

qPCR primers {#S14}
------------

*Cdx1:* acagccggtacatcactatcc, cttgtttactttgcgctccttg. *Cdx2:* tagtcgatacatcaccatcagg, tgattttcctctccttggctct. *Cdx4:* gcaatagatacatcaccatcagg, actttgcacggaacctccag. *Hoxa5:* tgtacgtggaagtgttcctgtc, gtcacagttttcgtcacagagc. *Hoxc6:* tagttctgagcagggcagga, cgagttaggtagcggttgaagt. *Hoxc8:* gtaaatcctccgccaacactaa, cgctttctggtcaaataaggat. *Hoxc9:* gcaagcacaaagaggagaagg, cgtctggtacttggtgtaggg. *HPRT:* agcaggtgttctagtcctgtgg, acgcagcaactgacatttctaa. *B-actin:* tgagagggaaatcgtgcgtgacat, accgctcgttgccaatagtgatga.

ChIP-chip protocols {#S15}
-------------------

ChIP protocols were adapted from <http://jura.wi.mit.edu/young_public/hESregulation/ChIP.html>. Briefly, approximately 3×10e7 cells taken from each developmental time point were cross-linked using formaldehyde and snap-frozen in liquid nitrogen. Cells were thawed on ice, resuspended in 5ml lysis buffer 1 (50 mM Hepes-KOH, pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100) and mixed on a rotating platform at 4°C for 5 minutes. Samples were spun down for 3 minutes at 3000rpm, resuspended in 5ml lysis buffer 2 (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA), and mixed on a rotating platform for 5 minutes at room temperature. Samples were spun down once more, resuspended in lysis buffer 3 (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine) and sonicated using a Misonix 3000 model sonicator to sheer cross-linked DNA to an average fragment size of approximately 500bp. Triton X-100 was added to the lysate after sonication to final concentrations of 1% and the lysate spun down to pellet cell debris. The resulting whole-cell extract supernatant was incubated on a rotating mixer overnight at 4°C with 100 μL of Dynal Protein G magnetic beads that had been preincubated for 24 hours with 10 μg of the appropriate antibody in a PBS/BSA solution. The following antibodies were used for ChIP experiments: antibodies against total H3 (Abcam, AB1791), H3K4me3 (Abcam, ab8580), H3K27me3 (Abcam, ab6002), H3K79me2 (Abcam, ab3594), and pan-RAR (Santa Cruz Biotechnology, sc- 773). After approximately 16 hours of bead-lysate incubation, beads were collected with a Dynal magnet. ChIP samples probing for transcription factor binding were washed with the following regimen, mixing on a rotating mixer at 4°C for 5 minutes per buffer: low-salt buffer (20 mM Tris at pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), high-salt buffer (20 mM Tris at pH 8.1, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), LiCl buffer (10 mM Tris at pH 8.1, 250 mM LiCl, 1 mM EDTA, 1% deoxycholate, 1% NP-40), and TE containing 50 mM NaCl. ChIP samples probing for histone and chromatin marks were washed 4 times with RIPA buffer (50 mM Hepes-KOH, pH 7.6, 500 mM LiCl, 1 mM EDTA, 1% NP-40, 0.7% Na-Deoxycholate) and then once with TE containing 50 mM NaCl, again mixing on a rotating mixer at 4°C for 5 minutes per buffer. After the final bead wash, samples were spun down to collect and discard excess wash solution, and bound antibody-protein-DNA fragment complexes were eluted from the beads by incubation in elution buffer at 65°C with occasional vortexing. Cross-links were reversed by overnight incubation at 65°C. Samples were digested with RNase A and Proteinase K to remove proteins and contaminating nucleic acids, and the DNA fragments precipitated with cold EtOH. Resulting purified DNA fragments were amplified via ligation-mediated (LM) PCR, labeled with a BioPrime CGH Genomic Labeling System (Invitrogen, 18095-011), and the labeled DNA co-hybridized to custom Agilent DNA microarrays.

Array design & hybridization {#S16}
----------------------------

Labeled DNA samples were co-hybridized to custom Agilent DNA microarrays using the Oligo aCGH/ChIP-on-chip Hybridization Kit (Agilent, 5188-5220) at 65°C for approximately 16 hours. Arrays were washed according to previously published protocols (<http://jura.wi.mit.edu/young_public/hESregulation/ChIP.html>).

The Agilent 244K probe arrays were designed to tile at least 400Kbp surrounding each of the four Hox clusters with an average probe spacing of 110bp. The remaining probes were used to tile +/− 30Kbp around the transcription start site of selected genes exhibiting differential patterns of expression during motor neuron differentiation, with probe spacing between 100bp and 150bp. The array design and all ChIP-chip array data were submitted to the NIH GEO database under accession number GSE19447.

ChIP-chip data analysis {#S17}
-----------------------

Arrays were scanned at dual PMT intensities (10% and 100%) at a 5um resolution using an Agilent microarray scanner. Feature extraction was performed with Agilent Feature Extraction software. Background subtracted values were normalized with (1) median normalization, (2) line fitting normalization, (3) quantile normalization; all normalization code was implemented in SQL as part of our in-house microarray database. Median normalization accounts for differences in the amount of dye hybridized between the two channels. This normalization multiplied IP intensities by median(control)/median(IP) such that the median intensity of the two channels is the same. Line fitting normalization is similar to Loess normalization but with a simpler model; it assumes that the bulk of the data should fall along the line y=x. Line fitting performed linear regression on the IP values as a function of the control and then rotated the datapoints such that the resulting line had slope one and intercept zero; this transformation is performed in log space. Finally, in order to allow comparison of probe intensities across time-points, arrays were quantile normalized ^[@R48]^. Heatmap style figures ([Figures: 1C](#F1){ref-type="fig"}, [S2](#SD1){ref-type="supplementary-material"}) were generated in MATLAB by plotting the time-series of smoothed array probe intensities, where the smoothing calculated average intensities across a sliding window of 500bp and an offset of 250bp.

Histone modification quantification {#S18}
-----------------------------------

A 2-state Hidden Markov Model was used to find the boundaries of H3K27me3-enriched domains at each time-point. Initial probabilities, transition probabilities, and Gaussian distributions for each state were estimated using the scaled Baum-Welch learner in the JaHMM Java library (<http://www.run.montefiore.ulg.ac.be/~francois/software/jahmm>).

To compare the dynamics of H3K27me3 and H3K79me2 at the promoter regions of Hox genes, we calculated the mean intensity of the probes in 1kb regions centered around the transcription start site of each gene at each time point. To determine the significance of differences in observed H3K27me3 and H3K79me2 levels at individual Hox genes, we infer the experimental variance for a given enrichment level by modeling mean-variance relationships across experimental replicates for all 1Kbp regions represented on the tiling arrays.

In order to determine whether a linear relationship exists between the dynamics of repressive histone modifications and Hox gene transcription after the addition of RA, we summarized the amount of H3K27me3 present near Hoxa1-5 by taking the average enrichment of the modification in a 4 kb window centered around the transcription start site (TSS) for each gene. The H3K27me3 enrichment and expression values (obtained by microarray analysis) were each normalized to the maximal value obtained for each gene over the course of the time series. A standard linear additive regression model was fitted to the H3K27me3/expression pairs from the entire time series using the least-squares method. The coefficient of determination (R^2^) for the fit of this model to these data is 0.7307. This may be interpreted as the proportion of variability in the data that is captured by the model. For the entire time series, a linear additive model captures a good portion of the variability in the data as noted by the observation that the onset of gene transcription occurs simultaneously with the initial domain wide removal of the repressive mark. We then limited our analysis to only the data obtained after the exposure to RA. R^2^ for the fit of the model to these data is equal to 0.0874. A much lower portion of the variability in these data is captured by a linear additive model. Thus, there is very little evidence of a linear relationship between H3K27me3 and expression after the initial onset of transcription that follows exposure to RA.

ChIP-seq protocols {#S19}
------------------

Samples analyzed by ChIP-seq were prepared similarly to ChIP-chip samples except that purified DNA fragments were not amplified via LM-PCR but were instead processed according to a modified version of the Illumina/Solexa sequencing protocol (Illumina, <http://www.illumina.com/pages.ilmn?ID=252>). ChIP-sequencing reads for RAR were aligned to the mouse genome (version mm8) as described previously ^[@R19]^ using Bowtie^[@R49]^version 0.9.9.2 with options -k 2 \--best. ChIP-sequencing reads for Cdx2 and H3K27me3 were aligned to the mouse genome (version mm8) using Bowtie version 0.12.5 with options -q \--best \--strata -m 1 -p 4 \--chunkmbs 1024. Only uniquely mapping reads were analyzed further. Multiple hits aligning to an individual nucleotide position are discarded above the level expected at a 10^−7^ probability from a per-base Poisson model of the uniquely mappable portion of the mouse genome. RAR binding event analysis was performed as described previously ^[@R19]^, and Cdx2 binding event analysis performed using GPS ^[@R50]^. Motifs occurring at RAR and Cdx2 peaks were discovered using GimmeMotifs (with settings "-w 200 -a large -g mm8 -f 0.5 -l 500"), which combines results from the motif-finders MDmodule, MEME, GADEM, MotifSampler, trawler, Improbizer, MoAn, and BioProspector. Scaling ratios to allow comparison of H3K27me3 levels across experiments were determined using a regression analysis of read counts occurring in 10Kbp windows along the mouse genome. Raw sequencing data (FASTQ format) was submitted to the NIH GEO/SRA database under accession numbers GSE19409 (RAR), GSE39433 (Cdx2 and H3K27me3 in Cdx2 induced cells), and GSE47485 (H3K27me3 for PcG cell lines).
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![Domain-wide clearance of repressive histone modifications and changes in *Hox* gene expression in response to RA\
A) Expression profiling of ESCs and day 7 RA/Hh treated embryoid bodies differentiated into motor neurons. RA treatment induces rostral *Hox1-5* gene expression (yellow). The color indicates log~2~ fold change in signal intensity between ESCs and Day 7 differentiated cells. Genes in gray are not represented on GeneChip arrays.\
B) *HoxA* chromatin is parceled during motor neuron differentiation into two domains, distinguished by different densities of H3K4me3 and H3K27me3 histone modifications. The red tracks represent H3K27me3 enrichment over 150 kb genomic region spanning *HoxA* cluster at Day 0 (ESCs) and Day 4 (progenitors). Blue peaks represent RAR binding 8 hours after RA/Hh treatment on Day 2^[@R19]^. The color of the genes indicates log~2~ fold change in signal intensity between ESCs and Day 7.\
C) Rapid and synchronous removal of H3K27me3 modifications from *Hoxa1-a5* domain. The heat map represents enrichment of H3K27me3 and H3K79me2 histone modifications along *HoxA* cluster at five time points during motor neuron differentiation.\
D) Temporal changes in H3K79me2 and H3K27me3 modifications over *Hoxa1* and *Hoxa5* genes. The values reflect average enrichment of modifications over 1kb genomic regions flanking transcription start sites. Note the delayed accumulation of H3K79me2 modifications in *Hoxa5* gene (marking actively transcribed chromatin), compared to the rapid clearance of repressive H3K27me3 modifications over the same chromatin territory. (n=2, ± SD).](nihms-505615-f0001){#F1}

![Patterns of *Hox* gene expression in Suz12^βgal/βgal^ cells differentiated to motor neurons\
A) Decreased density of H3K27me3 histone modification over 150 kb region spanning *HoxA* cluster in Suz12^βgal/βgal^ ESCs. Positive relative enrichment in H3K27me3 levels in Suz12^βgal/βgal^ over control cells are colored in red and negative relative enrichment in green.\
B) A fraction of Suz12^βgal/βgal^ motor neurons express Hoxc6 and Foxp1 proteins, markers of brachial spinal motor neurons. Although differentiation of Suz12^βgal/βgal^ cells is compromised, cells that acquired motor neuron identity (Hb9^+^) are detected at Day 7 of differentiation. Some of Suz12^βgal/βgal^ motor neurons acquired expression of a brachial marker Hoxc6 and a marker of brachial limb innervating motor neurons Foxp1. Scale bar = 50μm\
C) Upregulation of brachial *Hox* genes in Suz12^βgal/βgal^ motor neurons. Quantitative PCR analysis of *Hoxa5, Hoxa7, Hoxc6* and *Hoxa10* mRNA levels on Day 7. The *Hox* mRNA levels in Suz12 mutant cells are normalized to control cells. (n=3, p\<0.05).\
D) Suz12^βgal/βgal^ motor neurons acquire limb innervating identity. Deregulation of *Hox* gene expression in Suz12^βgal/βgal^ cells results in a significant increase in the number of Hb9+ motor neurons expressing Foxp1, downregulation of Lhx3 and an increase of Isl1+ motor neurons expressing Raldh2. (Mean ± sem. n=3, p\<0.05).\
E) Quantitative RT-PCR analysis of dynamic changes in *Hoxa1, Hoxa5, Hoxa7, Hoxb1, Hoxb4* and *Hoxb8* transcripts relative to their maximal levels. Analysis of RNA samples collected at five time points during differentiation of Suz12^βgal/βgal^ cells revealed a collinear expression profile of *Hox* genes.](nihms-505615-f0002){#F2}

![Wnt3A and FGF2 induce Cdx2 and caudalize differentiating motor neurons\
A) Wnt3A and FGF2 signaling induce caudal *Hox* gene expression and LMC character. motor neurons from dissociated cell cultures derived from Hh/RA/Wnt/FGF differentiation are labeled by the *Hb9::GFP* transgene (gray) and stained with antibodies against Hoxa5, Hoxc6 or Foxp1 (red) and Hoxc8, Hoxc9 and Lhx3 (green). Scale bar = 25μm\
B) Quantification of *Hox* gene expression in motor neurons (% of Hb9::GFP^+^ cells).\
C) Quantification of the columnar markers Foxp1 and Lhx3 in motor neurons (% of Hb9::GFP^+^ cells). (Mean ± sem. n=3).\
D) Hh/RA/Wnt/FGF caudalization protocol induces Cdx2. *Cdx2* mRNA levels normalized to control cultures treated only with RA/Hh 24 hours after the addition of patterning signals (Day 3 of differentiation).\
E) Cdx2 protein expression in differentiating cells 24 (Day 3) and 48 hours (Day 4) after Hh/RA/Wnt/FGF treatment. Scale bar = 20μm (Day 3), 50μm (Day 4)](nihms-505615-f0003){#F3}

![Cdx2 induces caudal *Hox* gene expression during motor neuron differentiation\
A) Diagram of an inducible V5 tagged Cdx2 ESC line (iCdx2). Control and induced iCdx2 ESCs stained with anti Cdx2 (red) and Oct4 (green) antibodies demonstrate that tagged Cdx2 is able to repress Oct4 expression. TetOP: Tetracycline Operator. V5: V5 epitope tag. pA: Polyadenylation signal. Scale bar = 20μm\
B) The expression of Cdx2 in combination with FGF2 treatment induces caudal *Hox* gene expression during motor neuron differentiation. Day 7 cultures from the Hh/RA (RA Hh), Hh/RA/Dox/FGF (Cdx2 FGF) and Hh/RA/FGF (FGF) were stained with anti Hoxc4, Hoxa5, Hoxc6, Hoxc8 or Hoxc9 (red) and Hb9 (green). Scale bar = 20μm\
C) Quantification of B).\
D) Expression of *Hox* genes at Day 5 of differentiation during Hh/RA/Dox/FGF motor neuron differentiation. The color of the boxes indicates log~2~ fold change in signal intensity between ES cells and Day 5. Gray boxes indicate genes that are not represented on the GeneChip arrays.](nihms-505615-f0004){#F4}

![Cdx2 directly controls *Hox* gene expression and chromatin modifications\
A) Cdx2 protein associates with *Hox* regulatory regions. The track represents the read count of Cdx2 ChIP-seq experiment over the 35 kb region of *HoxC* cluster. Blue peaks are significantly enriched over control (*p*\<0.001) suggesting Cdx2 binding. Blue arrows under the ChIP-seq track represent locations of matches to the Cdx2 motif in B).\
B) The primary motif enriched under Cdx2 ChIP-seq peaks.\
C) *HoxA* chromatin boundary is established between *Hoxa9* and *Hoxa10* after Cdx2 induction. The red tracks represent H3K27me3 enrichment over 150 kb genomic region including the *HoxA* cluster at Day 0 (ESC stage) and Day 5. The center track represents Cdx2 binding on Day4. Blue peaks denote Cdx2 ChIP-seq signal significantly enriched above background (*p*\<0.001). The color of the genes indicates log~2~ fold change in signal intensity between ES cells and Day 5.](nihms-505615-f0005){#F5}

![The sequential activity of RAR and Cdx2 establishes two distinct chromatin states\
A) Relative changes in K27me3 chromatin modifications in *HoxA* cluster (150 kb) during cervical and brachial/thoracic motor neuron differentiation. The tracks represent the H3K27me3 difference between Day 0 and Day 4 (Hh/RA) or Day 5 (Hh/RA/Cdx2/FGF). Positive relative enrichment levels are colored in red and negative relative enrichment in green. The color of the genes indicates log~2~ fold change in mRNA levels between the caudal (Hh/RA/Cdx2/FGF) and rostral (Hh/RA) protocols. Gray boxes indicate genes that are not represented on the GeneChip arrays. Note the repression (blue color) of rostral *Hox* genes concomitant with the upregulation of *Hoxa9* (yellow color).\
B) RAR and Cdx2 associate with local and putative distal regulatory regions. The tracks represent ChIP-seq enrichment levels for RAR and Cdx2, top and bottom respectively over 500 kb region spanning *HoxB* cluster and distal binding sites within *Scap1* locus. Blue peaks are significantly enriched over control (*p*\<0.001).](nihms-505615-f0006){#F6}
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